Positron Corp. (OTCMKTS:POSC) Sees Significant Decline in Short Interest

Positron Corp. (OTCMKTS:POSC) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 262 shares, a decline of 97.1% from the September 30th total of 9,086 shares. Based on an average daily trading volume, of 32,692 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Positron Trading Up 1.5%

OTCMKTS:POSC opened at $1.70 on Tuesday. The stock has a 50 day moving average of $1.74 and a two-hundred day moving average of $1.82. Positron has a 12 month low of $1.27 and a 12 month high of $2.74. The firm has a market cap of $56.27 million, a P/E ratio of -5.31 and a beta of 0.53.

Positron (OTCMKTS:POSC) last released its earnings results on Friday, August 14th. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $0.11 million during the quarter. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%.

About Positron

Positron Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers.

The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions.